Pitfalls in cytokine measurements – Plasma TGF-β1 in chronic fatigue syndromeIssue: September 2018, Volume: 76, Number: 7
M.E. Roerink,
M.E. van der Schaaf,
L.J.A.C. Hawinkels,
R.P.H. Raijmakers,
H. Knoop,
L.A.B. Joosten,
J.W.M. van der Meer
Pitfall of modern genetics: recurrent erysipelas masquerading as autoinflammatory diseaseIssue: July 2017, Volume: 75, Number: 6
E.J.W. Spierings,
J.W.M. van der Meer,
A. Simon
Cutaneous hyperpigmentation induced by doxycycline: a case seriesIssue: January 2015, Volume: 73, Number: 1
S.P. Keijmel,
M.E.E. van Kasteren,
W.A.M. Blokx,
J.W.M. van der Meer,
M. van Rossum,
C.P. Bleeker-Rovers
The challenge of Lyme disease: tired of the Lyme warsIssue: March 2011, Volume: 69, Number: 3
B.J. Kullberg,
A. Berende,
J.W.M. van der Meer
Anakinra for the inflammatory complications of chronic granulomatous diseaseIssue: February 2011, Volume: 69, Number: 2
F.L. van de Veerdonk,
M.G. Netea,
C.A. Dinarello,
J.W.M. van der Meer
Chronic yersiniosis due to defects in the TLR5 and NOD2 recognition pathwaysIssue: October 2010, Volume: 68, Number: 10
M.G. Netea,
F. van der Leij,
J.P.H. Drenth,
L.A.B. Joosten,
R. te Morsche,
P. Verweij,
D. de Jong,
B-J. Kullberg,
J.W.M. van der Meer
Benign uterine uptake of FDG: a case report and review of literatureIssue: September 2010, Volume: 68, Number: 9
D. Vriens,
L.F. de Geus-Oei,
U.E. Flucke,
A.J. van der Kogel,
W.J.G. Oyen,
M.E. Vierhout,
J.W.M. van der Meer
Complete remission of severe idiopathic cold urticaria on interleukin-1 receptor antagonist (anakinra)Issue: October 2009, Volume: 67, Number: 9
E.J. Bodar,
A. Simon,
M. de Visser,
J.W.M. van der Meer
50 years Netherlands Journal of Medicine - 2002, reshaping the journalIssue: October 2008, Volume: 66, Number: 9
J.W.M. van der Meer
Defective interferon-gamma production in patients with hairy cell leukaemiaIssue: September 2008, Volume: 66, Number: 8
M.G. Netea,
O. Hoitink,
B.J. Kullberg,
J.W.M. van der Meer,
R. Raymakers
Reversible hypogammaglobulinaemiaIssue: November 2007, Volume: 65, Number: 10
I.M.E. Desar,
C.M.R. Weemaes,
M. van Deuren,
J.W.M. van der Meer
Independent medical researchIssue: April 2007, Volume: 65, Number: 4
J.W.M. van der Meer,
A.M. de Gier,
W.P.M. van Swaaij,
M.B. Katan
Recurrent erysipelas despite antibiotic prophylaxis: an analysis from case studiesIssue: March 2007, Volume: 65, Number: 3
J.B. Koster,
B.J. Kullberg,
J.W.M. van der Meer
Extranodal marginal zone (MALT) lymphoma in common variable immunodeficiency: a report of two cases and a brief review of the literatureIssue: May 2006, Volume: 64, Number: 5
I.M.E. Desar,
M. Keuters,
J.M.M. Raemaekers,
J.B.M.J. Jansen,
J.H.J. van Krieken,
J.W.M. van der Meer
NOD2 3020insC mutation and the pathogenesis of Crohn’s disease: impaired IL-1β production points to a loss-of-function phenotypeIssue: September 2005, Volume: 63, Number: 8
M.G. Netea,
G. Ferwerda,
D.J. de Jong,
S.E. Girardin,
B.J. Kullberg,
J.W.M. van der Meer
Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccination provocation modelIssue: July-August 2005, Volume: 63, Number: 7
E.J. Bodar,
J.C.H. van der Hilst,
J.P.H. Drenth,
J.W.M. van der Meer,
A. Simon
Side effects of anticytokine strategiesIssue: March 2005, Volume: 63, Number: 3
J.W.M. van der Meer,
C. Popa,
M.G. Netea
Clinical outcome of experimental human malaria induced by Plasmodium falciparum-infected mosquitoesIssue: February 2005, Volume: 63, Number: 2
D.F. Verhage,
D.S.C. Telgt,
J.T. Bousema,
C.C. Hermsen,
GJ.A. van Gemert,
J.W.M. van der Meer,
R.W. Sauerwein
Antibiotic control measures in Dutch secondary care hospitalsIssue: January 2005, Volume: 63, Number: 1
J.A. Schouten,
M.E.J.L. Hulsche,
S. Natsch,
R.P.T.M. Grol,
J.W.M. van der Meer
Why don’t medical textbooks teach? The lack of logic in the differential diagnosisIssue: November 2003, Volume: 61, Number: 11
P.M.J. Stuyt,
,
J.W.M. van der Meer
Candida-specific interferon-ã deficiency and Toll-like receptor polymorphisms in patients with chronic mucocutaneous candidiasisIssue: November 2003, Volume: 61, Number: 11
C.A.A. van der Graaf,
M.G. Netea,
J.P.H. Drenth,
R.H. te Morsche,
J.W.M. van der Meer,
B.J. Kullberg
F-18-fluorodeoxyglucose positron emission tomography in diagnosis and follow-up of patients with different types of vasculitisIssue: October 2003, Volume: 61, Number: 10
C.P. Bleeker-Rovers,
S.J.H. Bredie,
J.W.M. van der Meer,
F.H.M. Corstens,
W.J.G. Oyen
Genetic basis of host susceptibility to infections - PrefaceIssue: Supplement March 2004, Volume: 62, Number: 3
B.M. de Jongh,
S. de Marie,
J.W.M. van der Meer,
C.M.J.E. Vandenbroucke-Grauls,
H.A. Verbrugh
Primary haemochromatosis: a missed cause of chronic fatigue syndrome?Issue: December 2002, Volume: 60, Number: 11
D.W. Swinkels,
N. Aalbers,
L.D. Elving,
G. Bleijenberg,
C.M.A. Swanink,
J.W.M. van der Meer
Abstract!Issue: December 2002, Volume: 60, Number: 11
J.W.M. van der Meer,
A.F.H. Stalenhoef,
P. Smits,
Th. Thien
Diagnosing chronic fatigue syndrome: comparison of a protocol and computerised questionnairesIssue: April 2003, Volume: 61, Number: 4
J.B. Prins,
L.D. Elving,
H. Koning,
G. Bleijenberg,
J.W.M. van der Meer
Why publish in the Netherlands Journal of Medicine?Issue: April 2003, Volume: 61, Number: 4
Th. Thien,
J.W.M. van der Meer,
A.F.H. Stalenhoef,
P. Smits
Substitution therapy in immunodeficient patients with anti-IgA antibodies or severe adverse reactions to previous immunoglobulin therapyIssue: June 2003, Volume: 61, Number: 6
H.W. Eijkhout,
P.J. van den Broek,
J.W.M. van der Meer
Immunomodulation by antimicrobial drugsIssue: July 2003, Volume: 61, Number: 7
J.W.M. van der Meer
The effect of granisetron, a 5-HT3 receptor antagonist, in the treatment of chronic fatigue syndrome patients – a pilot studyIssue: September 2003, Volume: 61, Number: 9
G.K.H. The,
J. Prins,
G. Bleijenberg,
J.W.M. van der Meer
